EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula

Dimitris Basoulis iD, Pantelis Avramopoulos iD, Maria Aggelara iD, Georgios Karamanakos iD, Pantazis-Michail Voutsinas iD, Amalia Karapanou iD, Mina Psichogiou iD, Michalis Samarkos iD, Foteini Ntziora iD, Nikolaos V Sipsas iD

Canadian Respiratory Journal · 2023

DOI: 10.1155/2023/7474564 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Canadian Respiratory Journal, 2023. Verfasst von Dimitris Basoulis und 9 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and COVID-19 Unit, Athens, Greece. Hauptthemen laut MEDLINE: COVID-19, Respiratory Insufficiency, Noninvasive Ventilation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

High-flow nasal cannula (HFNC) is an oxygen delivery method shown to reduce the risk of intubation and mortality in patients with type 1 respiratory failure. The ROX-index score can predict HFNC failure. This study aims to evaluate sequential ROX-index assessments as predictors of HFNC failure and mortality.

Methods

Prospective observational single-center study including all adult patients with positive SARS-CoV-2 PCR placed under HFNC from 1st November 2020 to 31st May 2021, and patients with hemodynamic instability or unable to tolerate HFNC were excluded. The primary endpoint was successful HFNC de-escalation.

Results

In univariate analysis, HFNC de-escalation was associated with younger age (59.2 ± 14 vs. 67.7 ± 10.5 and p < 0.001 ), lower levels of serum lactate (1.1 vs. 1.5 and p = 0.013 ), and higher ROX-index at 12 hrs (5.09 vs. 4.13 and p < 0.001 ). ROC curve analysis of ROX-index at 12 hrs yielded a c-statistic of 71.2% (95% CI 61.6–80.9 and p < 0.001 ). ROX-index at 12 hrs and age retained significance in multivariate analysis. Using an optimal cutoff point of 4.43, we calculated a sensitivity of 64.5% and specificity of 69.6%. In univariate survival analysis, older age (68.8 ± 9.7 vs. 58.9 ± 13.9 and p < 0.001 ), greater creatinine values (0.96 vs. 0.84 and p = 0.022 ), greater SOFA score ( p = 0.039 ), and a lower 12 hrs ROX-index (4.22 vs. 4.95 and p = 0.02 ) were associated with hospital mortality. The SOFA score and age retained significance in multivariate survival analysis.

Conclusion

ROX-index is proven to be a valuable and easy-to-use tool for clinicians in the assessment of COVID-19 patients under HFNC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Respiratory InsufficiencyNoninvasive VentilationAdultHumansOxygenCannulaSARS-CoV-2Treatment FailureOxygen Inhalation Therapy

Substanzen

Oxygen

Autor:innen und Institutionen

  • Infectious Diseases and COVID-19 Unit, Athens, Greece.
  • 1st Internal Medicine Department, Athens, Greece.
  • 1st Propaedeutic Internal Medicine Department, Athens, Greece.
  • Infection Control Nurse, Athens, Greece.
  • Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens "Laiko" General Hospital, Athens, Greece.

ORCID-Profile: Dimitris Basoulis, Pantelis Avramopoulos, Maria Aggelara, Georgios Karamanakos, Pantazis-Michail Voutsinas, Amalia Karapanou, Mina Psichogiou, Michalis Samarkos, Foteini Ntziora, Nikolaos V Sipsas

Zitieren

APA

Basoulis, D., Avramopoulos, P., Aggelara, M., Karamanakos, G., Voutsinas, P. M., Karapanou, A., Psichogiou, M., Samarkos, M., Ntziora, F., & Sipsas, N. V. (2023). Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula. Canadian Respiratory Journal. https://doi.org/10.1155/2023/7474564

Vancouver

Basoulis D, Avramopoulos P, Aggelara M, Karamanakos G, Voutsinas PM, Karapanou A, et al. Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula. Canadian Respiratory Journal. 2023. doi:10.1155/2023/7474564

BibTeX
@article{Basoulis2023,
  author = {Basoulis, Dimitris and Avramopoulos, Pantelis and Aggelara, Maria and Karamanakos, Georgios and Voutsinas, Pantazis-Michail and Karapanou, Amalia and Psichogiou, Mina and Samarkos, Michalis and Ntziora, Foteini and Sipsas, Nikolaos V},
  title = {Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula},
  journal = {Canadian Respiratory Journal},
  year = {2023},
  doi = {10.1155/2023/7474564}
}
Kostenlos starten →